Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 3, 2011, Pages 1606-1612

  Mullins, Robert F ^a   Johnson, Micaela N ^a   Faidley, Elizabeth A ^a   Skeie, Jessica M ^a   Huang, Jian ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD VESSEL DENSITY; BLOOD VESSEL PARAMETERS; CELL LOSS; CHOROID CAPILLARY LAYER; CONTROLLED STUDY; DRUSEN; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE COUNT; MICROVASCULAR ENDOTHELIAL CELL; MORPHOMETRICS; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA MACULA AGE RELATED DEGENERATION;

AGED; AGED, 80 AND OVER; ANTIGENS, CD45; CAPILLARIES; CHOROID; CHOROIDAL NEOVASCULARIZATION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LEUKOCYTES; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETINAL DRUSEN; RETINAL PIGMENT EPITHELIUM; TISSUE DONORS;

EID: 79955937288     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6476     Document Type: Article

References (60)

1. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol. 2001;119: 1417-1436.
2. Zarbin M. Age-related macular degeneration: review of pathogenesis. [Review] [65 refs]. Eur J Ophthalmol. 1998;8:199-206.
3. Stone EM. A very effective treatment for neovascular macular degeneration. N Engl J Med. 2006;355:1493-1495.
4. Gass J. Drusen and disciform macular detachment and degeneration. Arch. Ophthalmol. 1973;90:206-217.
5. Sarks S. Ageing and degeneration in the macular region: a clinicopathological study. Br J Ophthalmol. 1976;60:324-341.
6. Pauleikhoff D, Barondes M, Minassian D, Chisholm I, Bird A. Drusen as risk factors in age-related macular disease. Am J Ophthalmol. 1990;109:38-43.
7. Curcio C, Millican C. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol. 1999;117:329-339.
8. van der Schaft T, Mooy C, de Bruijn W, de Jong P. Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study. Br J Ophthalmol. 1993;77:657-661.
9. Mullins R, Anderson D, Russell S, Hageman G. Ocular drusen contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000;14:835-846.
10. Johnson L, Ozaki S, Staples M, Erickson P, Anderson D. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res. 2000;70:441-449.
11. Anderson D, Mullins R, Hageman G, Johnson L. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134:411-431.
12. Crabb JW, Miyagi M, Gu X, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A. 2002;99:14682-14687.
13. Wang L, Clark ME, Crossman DK, et al. Abundant lipid and protein components of drusen. PLoS ONE. 5:e10329.
14. Friedman E, Smith T, Kuwabara T. Senile choroidal vascular patterns and drusen. Arch Ophthalmol. 1963;69:220-230.
15. Sarks S, Arnold J, Killingsworth M, Sarks J. Early drusen formation in the normal and aging eye and their relation to age-related maculopathy: a clinicopathological study. Br J Ophthalmol. 1999; 83:358-368.
16. Lengyel I, Tufail A, Hosaini HA, Luthert P, Bird AC, Jeffery G. Association of drusen deposition with choroidal intercapillary pillars in the aging human eye. Invest Ophthalmol Vis Sci. 2004;45: 2886-2892.
17. Kochounian H, Johnson LV, Fong HK. Accumulation of extracellular RGR-d in Bruch's membrane and close association with drusen at intercapillary regions. Exp Eye Res. 2009;88:1129-1136.
18. Barthel L, Raymond P. Improved method for obtaining 3-microns cryosections for immunocytochemistry. J Histochem Cytochem. 1990;38:1383-1388.
19. Mullins R, Grassi M, Skeie J. Glycoconjugates of choroidal neovascular membranes in age-related macular degeneration. Mol Vis. 2005;11:509-517.
20. Mullins R, Skeie J, Malone E, Kuehn M. Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina. Mol Vis. 2006;12:224-235.
21. Wessa P. Linear Regression Graphical Model Validation (v1.0.6) in Free Statistics Software (v1.1.23-r6). Office for Research Development and Education; 2008.
22. Haddad S, Chen CA, Santangelo SL, Seddon JM. The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol. 2006;51:316-363.
23. Mullins RF. Genetic insights into the pathobiology of age-related macular degeneration. Int Ophthalmol Clin. 2007;47:1-14.
24. Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res. 2009;28:1-18.
25. Winkler B, Boulton M, Gottsch J, Sternberg P. Oxidative damage and age-related macular degeneration. Mol Vis. 1999;5:32.
26. Wong RW, Richa DC, Hahn P, Green WR, Dunaief JL. Iron toxicity as a potential factor in AMD. Retina. 2007;27:997-1003.
27. Malek G, Li C, Guidry C, Medeiros N, Curcio C. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am J Pathol. 2003;162:413-425.
28. Nordgaard CL, Berg KM, Kapphahn RJ, et al. Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2006;47:815-822.
29. Jarrett SG, Lin H, Godley BF, Boulton ME. Mitochondrial DNA damage and its potential role in retinal degeneration. Prog Retin Eye Res. 2008;27:596-607.
30. Feigl B. Age-related maculopathy - linking aetiology and pathophysiological changes to the ischaemia hypothesis. Prog Retin Eye Res. 2009;28:63-86.
31. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 2004;122:598-614.
32. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48:257-293.
33. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2006;51:137-152.
34. Zarbin MA, Rosenfeld PJ. Pathway-based therapies for age-related macular degeneration: an integrated survey of emerging treatment alternatives. Retina. 30:1350-1367.
35. Hageman G, Anderson D, Johnson L, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A. 2005;102:7227-7232.
36. Seth A, Cui J, To E, Kwee M, Matsubara J. Complement-associated deposits in the human retina. Invest Ophthalmol Vis Sci. 2008;49: 743-750.
37. Abrera-Abeleda M, Nishimura C, Smith J, et al. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J Med Genet. 2006;43: 582-589.
38. Skeie JM, Fingert J, Russell S, Stone EM, Mullins RF. Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells. Invest Ophthalmol Vis Sci. In press.
39. Friedman E, Krupsky S, Lane A, et al. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology. 1995;102:640-646.
40. Pauleikhoff D, Spital G, Radermacher M, Brumm G, Lommatzsch A, Bird A. A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. Arch Ophthalmol. 1999;117:1353-1358.
41. Chen S, Cheng C, Lee A, et al. Pulsatile ocular blood flow in asymmetric exudative age-related macular degeneration. Br J Opthtalmol. 2001;85:1411-1415.
42. Mori F, Konno S, Hikichi T, Yamaguchi Y, Ishiko S, Yoshida A. Pulsatile ocular blood flow study: decreases in exudative age related macular degeneration. Br J Ophthalmol. 2001;85:531-533.
43. Grunwald J, Hariprasad S, DuPont J, et al. Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1998;39:385-390.
44. Vingerling J, Dielemans I, Bots M, Hofman A, Grobbee D, de Jong P. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol. 1995;142:404-409.
45. Klein R, Klein B, Jensen S. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997; 104:1804-1812.
46. Hyman L, Schachat A, He Q, Leske M. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol. 2000;118:351-358.
47. Anand R, Bressler S, Davis M, et al. Risk factors associated with age-related macular degeneration: a case-control study in the Age-Related Eye Disease Study: Age-Related Eye Disease Study report number 3. Ophthalmology. 2000;107:2224-2232.
48. Lip P, Blann A, Hope-Ross M, Gibson J, Lip G. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology. 2001;108:705-710.
49. Ramrattan R, van der Schaft T, Mooy C, de Bruijn W, Mulder P, de Jong P. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol Vis Sci. 1994;35:2857-2864.
50. Spraul C, Lang G, Grossniklaus H. Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37:2724-2735.
51. Spraul C, Lang G, Grossniklaus H, Lang G. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol. 1999;44:S10-32.
52. McLeod DS, Grebe R, Bhutto I, Merges C, Baba T, Lutty GA. Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009;50:4982-4991.
53. Kuroki A, Bhutto I, Kitaoka T, Amemiya T. Natural course of experimental choroidal neovascularization: three-dimensional study with corrosion cast and scanning electron microscope. Ophthalmic Res. 2002;34:200-205.
54. Lutty GA, McLeod DS. Phosphatase enzyme histochemistry for studying vascular hierarchy, pathology, and endothelial cell dysfunction in retina and choroid. Vision Res. 2005;45:3504-3511.
55. Miettinen M, Holthofer H, Lehto VP, Miettinen A, Virtanen I. Ulex europaeus I lectin as a marker for tumors derived from endothelial cells. Am J Clin Pathol. 1983;79:32-36.
56. Penfold P, Killingsworth M, Sarks S. Senile macular degeneration: the involvement of immunocompetent cells. Graefe's Arch Clin Exp Ophthalmol. 1985;223:69-76.
57. Xu W, Grunwald JE, Metelitsina TI, et al. Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation. Am J Ophthalmol. 150:40-47 e42.
58. Bressler N, Silva J, Bressler S, Fine S, Green W. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina. 1994;14:130-142.
59. Ezzat MK, Hann CR, Vuk-Pavlovic S, Pulido JS. Immune cells in the human choroid. Br J Ophthalmol. 2008;92:976-980.
60. Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D'Amore PA. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci U S A. 2009;106: 18751-18756